PROSPECTIVE EVALUATION OF CARCINOEMBRYONIC ANTIGEN LEVELS AND ALTERNATING CHEMOTHERAPEUTIC REGIMENS IN METASTATIC BREAST-CANCER

[1] BOGDEN AE, 1978, BREAST CANCER ADV RE, V2, P283

[2] RANDOMIZED TRIAL OF LOW-DOSE VERSUS HIGH-DOSE MEDROXYPROGESTERONE ACETATE IN THE INDUCTION TREATMENT OF POSTMENOPAUSAL PATIENTS WITH ADVANCED BREAST-CANCER [J]. JOURNAL OF CLINICAL ONCOLOGY, 1984, 2 (05) : 414 - 419

[3] CHATAL JF, 1978, CLIN APPLICATION CAR, P263

[4] COX DR, 1972, J R STAT SOC B, V34, P187

[5] FALKSON HC, 1979, CANCER TREAT REP, V63, P1303

[6] FALKSON HC, 1982, CANCER, V49, P1859, DOI 10.1002/1097-0142(19820501)49:9<1859::AID-CNCR2820490919>3.0.CO

[7] 2-R

[8] FALKSON HC, 1978, CANCER, V42, P1308, DOI 10.1002/1097-0142(197809)42:3<1308::AID-CNCR2820420341>3.0.CO

[9] 2-N

[10] DRUG-RESISTANCE AND CANCER-CHEMOTHERAPY STRATEGY IN BREAST-CANCER [J]. BREAST CANCER RESEARCH AND TREATMENT, 1983, 3 (02) : 129 - 136

[1] BOGDEN AE, 1978, BREAST CANCER ADV RE, V2, P283

[2] RANDOMIZED TRIAL OF LOW-DOSE VERSUS HIGH-DOSE MEDROXYPROGESTERONE ACETATE IN THE INDUCTION TREATMENT OF POSTMENOPAUSAL PATIENTS WITH ADVANCED BREAST-CANCER [J]. JOURNAL OF CLINICAL ONCOLOGY, 1984, 2 (05) : 414 - 419

[3] CHATAL JF, 1978, CLIN APPLICATION CAR, P263

[4] COX DR, 1972, J R STAT SOC B, V34, P187

[5] FALKSON HC, 1979, CANCER TREAT REP, V63, P1303

[6] FALKSON HC, 1982, CANCER, V49, P1859, DOI 10.1002/1097-0142(19820501)49:9<1859::AID-CNCR2820490919>3.0.CO

[7] 2-R

[8] FALKSON HC, 1978, CANCER, V42, P1308, DOI 10.1002/1097-0142(197809)42:3<1308::AID-CNCR2820420341>3.0.CO

[9] 2-N

[10] DRUG-RESISTANCE AND CANCER-CHEMOTHERAPY STRATEGY IN BREAST-CANCER [J]. BREAST CANCER RESEARCH AND TREATMENT, 1983, 3 (02) : 129 - 136